Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra
- PMID: 9125443
- DOI: 10.1016/s0006-8993(97)00008-5
Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra
Abstract
Complex I dysfunction has been implicated in the pathogenesis of Parkinson's disease and in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which produces a Parkinsonian syndrome in experimental animals and humans. Rotenone is an insecticide which is a specific inhibitor of complex I. We examined the pattern of central nervous system damage produced by i.v. systemic administration of rotenone in rats. Rotenone produced selective damage in the striatum and the globus pallidus, but the substantia nigra was spared. These results are consistent with prior reports suggesting that the selective vulnerability of the substantia nigra to MPTP involves both uptake by the dopamine transporter as well as complex I inhibition, and they show that rotenone produces a unique pattern of central nervous system damage.
Similar articles
-
Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices.Exp Neurol. 2003 Jan;179(1):47-59. doi: 10.1006/exnr.2002.8044. Exp Neurol. 2003. PMID: 12504867
-
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.Exp Neurol. 2003 Jan;179(1):9-16. doi: 10.1006/exnr.2002.8072. Exp Neurol. 2003. PMID: 12504863
-
Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.Brain Res. 2016 Feb 15;1633:115-125. doi: 10.1016/j.brainres.2015.12.036. Epub 2015 Dec 29. Brain Res. 2016. PMID: 26740407
-
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.J Neural Transm Suppl. 1986;20:11-39. J Neural Transm Suppl. 1986. PMID: 3091760 Review.
-
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?Lancet Neurol. 2003 Sep;2(9):531-8. doi: 10.1016/s1474-4422(03)00501-5. Lancet Neurol. 2003. PMID: 12941575 Review.
Cited by
-
LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.Mol Nutr Food Res. 2013 Aug;57(8):1410-22. doi: 10.1002/mnfr.201200801. Epub 2013 May 3. Mol Nutr Food Res. 2013. PMID: 23650208 Free PMC article.
-
4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN.EMBO Mol Med. 2019 Dec;11(12):e10489. doi: 10.15252/emmm.201910489. Epub 2019 Oct 29. EMBO Mol Med. 2019. PMID: 31660701 Free PMC article.
-
Rotenone induces cell death of cholinergic neurons in an organotypic co-culture brain slice model.Neurochem Res. 2009 Dec;34(12):2147-53. doi: 10.1007/s11064-009-0014-9. Neurochem Res. 2009. PMID: 19495971 Free PMC article.
-
Mapping the Research of Ferroptosis in Parkinson's Disease from 2013 to 2023: A Scientometric Review.Drug Des Devel Ther. 2024 Apr 3;18:1053-1081. doi: 10.2147/DDDT.S458026. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38585257 Free PMC article. Review.
-
Animal models of the non-motor features of Parkinson's disease.Neurobiol Dis. 2012 Jun;46(3):597-606. doi: 10.1016/j.nbd.2011.12.040. Epub 2012 Jan 3. Neurobiol Dis. 2012. PMID: 22236386 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources